This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 1999;281:408.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Editors of some of the most widely read and respected international medical journals have significantly revised their uniform requirements for manuscript submission (JAMA.1998;280:2035). The revision, by members of the International Committee of Medical Journal Editors, is intended to alleviate authors' concerns that reporting a public health hazard or major therapeutic advance directly to the FDA or other government agency or to the media may jeopardize subsequent medical journal publication of an article or letter to the editor on the same topic. The revision states that such reporting may be warranted "when the paper or letter describes major therapeutic advances or public health hazards such as serious adverse effects of drugs, vaccines, other biological products, or medical devices, or reportable diseases." It states that this reporting should not jeopardize publication but should be discussed with and agreed on by the journal editor in advance.

JAMA, which 5 years . . . [Full Text of this Article]